Kaeleen Franson
Optometrist · Salt Lake City, UTNPI 1780063784
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 74.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $4,697 and has fallen 85.1% since, to $698 in 2025. Among optometrist clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $74.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$6K
- Bausch & Lomb Americas Inc.$545
- Bausch & Lomb, A Division Of Bausch Health US, LLC$458
- Oyster Point Pharma, Inc.$147
- AbbVie$146
- Johnson & Johnson Surgical Vision, Inc.$118
- plus $543 from 9 others
What the payments were for
- Speaking & faculty fees$3,50045%
- Travel & lodging$1993%
- Food & beverage$4,02752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 54 | $5,769 |
| Bausch & Lomb Americas Inc. | 12 | $545 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $458 |
| Oyster Point Pharma, Inc. | 2 | $147 |
| AbbVie | 2 | $146 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $118 |
| Johnson & Johnson Vision Care, Inc. | 2 | $113 |
| Novartis | 5 | $90 |
| Sight Sciences, Inc. | 1 | $73 |
| LKC Technologies, Inc. | 1 | $73 |
| Alcon | 3 | $49 |
| Biotissue Holdings Inc. | 2 | $46 |
| Sun Pharmaceutical Industries Inc. | 2 | $46 |
| Tarsus Pharmaceuticals, Inc. | 1 | $33 |
| Maculogix, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiSight Contact Lens$3,959
- INFUSE$498
- MyDay Contact Lens$323
- RESTASIS$125
- ULTRA MULTIFOCAL TORIC$125
- BTOD$125
- TYRVAYA$122
- Clariti Contact Lens$111
How this compares
$7,726 in reported general payments places this provider in the 95th percentile of 423 optometrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Salt Lake City
- Sean CushmanSalt Lake City$25K
- Camron BatemanSalt Lake City$10K
- Karri BureshSalt Lake City$9K
- Leidy Dayan Monsalve-WardSalt Lake City$5K
- Rick RobisonSalt Lake City$4K
- Jeffrey SimmonsSalt Lake City$4K
- Ryan GarberSalt Lake City$4K
- Christopher ValliereSalt Lake City$3K
- Stephen ReinhartHill Afb$134K
- Robert WooldridgeMurray$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.